AVENUE THERAPEUTICS, INC. (ATXI) Corporate Subsidiaries
AVENUE THERAPEUTICS, INC. (ATXI) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ATXI
CIK: 1644963
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJoseph Epstein
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | FORM 10-Q | 0001437749-26-026372 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | FORM 10-Q | 0001437749-26-015759 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | FORM 10-K | 0001437749-26-010359 | View SEC Doc Filr Page |
| 8-K | 2026-02-23 | 2026-02-18 | FORM 8-K | 0001104659-26-018582 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001193125-26-055056 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-06 | — | SCHEDULE 13D/A Filing | 0001104659-26-001305 | View SEC Doc Filr Page |
| 4 | 2026-01-06 | 2026-01-02 | 4 Filing | 0001429260-26-000004 | View SEC Doc Filr Page |
| 8-K | 2025-12-31 | 2025-12-30 | FORM 8-K | 0001104659-25-125420 | View SEC Doc Filr Page |
| EFFECT | 2025-12-16 | — | EFFECT Filing | 9999999995-25-003776 | View SEC Doc Filr Page |
| POS AM | 2025-12-15 | — | POS AM | 0001104659-25-121247 | View SEC Doc Filr Page |
| RW | 2025-12-15 | — | RW | 0001104659-25-121121 | View SEC Doc Filr Page |
| DEF 14A | 2025-12-05 | 2025-12-30 | FORM DEF 14A | 0001437749-25-037023 | View SEC Doc Filr Page |
| 8-K | 2025-11-18 | 2025-11-14 | FORM 8-K | 0001437749-25-035624 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | FORM 10-Q | 0001437749-25-034821 | View SEC Doc Filr Page |
| 8-K | 2025-11-12 | 2025-11-05 | FORM 8-K | 0001437749-25-034243 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | FORM 10-Q | 0001437749-25-026935 | View SEC Doc Filr Page |
| 25-NSE | 2025-07-18 | — | 25-NSE Filing | 0001354457-25-000696 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | FORM 10-Q | 0001437749-25-017180 | View SEC Doc Filr Page |
| 8-K | 2025-04-30 | 2025-04-24 | FORM 8-K | 0001104659-25-042570 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-04-02 | — | SCHEDULE 13D/A Filing | 0001104659-25-031241 | View SEC Doc Filr Page |
| 4 | 2025-04-02 | 2025-03-31 | 4 Filing | 0001415889-25-009621 | View SEC Doc Filr Page |
| 10-K | 2025-03-31 | 2024-12-31 | FORM 10-K | 0001437749-25-010196 | View SEC Doc Filr Page |
| 8-K | 2025-03-17 | 2025-03-17 | FORM 8-K | 0001104659-25-024505 | View SEC Doc Filr Page |
| 8-K | 2025-03-07 | 2025-03-07 | FORM 8-K | 0001437749-25-006685 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-02-14 | — | SCHEDULE 13G/A Filing | 0001172661-25-001238 | View SEC Doc Filr Page |